C9orf72 and amyotrophic lateral sclerosis: We explore the therapeutic potential of PSNAs by delivering siRNA duplexes against C9orf72, a target for genetic treatment of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), to motor-neuron-like cells.